Literature DB >> 15648552

Location of functioning metastases from differentiated thyroid carcinoma by simultaneous double isotope acquisition of I-131 whole body scan and bone scan.

C Ceccarelli1, F Bianchi, D Trippi, F Brozzi, F Di Martino, P Santini, R Elisei, A Pinchera.   

Abstract

In a young patient with differentiated thyroid carcinoma (DTC), previously submitted to total thyroidectomy and I-131 therapy for ablation of thyroid remnant, a follow-up 1-131 diagnostic whole body scan (WBS) demonstrated four small abnormal I-131 uptake areas. Two of these were projected over the thoracic region and corresponded to lung nodules, as later demonstrated by lung computerized tomography (CT)-scan. The remaining two areas were found in the lumbar-pelvic region, but their precise location could not be determined. Standard bone Rx examination and bone scan were negative. After I-131 therapy, we simultaneously acquired a I-131 WBS and a Tc-99m oxidronate bone scan by setting a dual window on the gamma camera. Comparing the I-131 and bone images we were able to identify the 4th lumbar vertebra and right ilium as the bone segments to be studied by a radiological approach. Eventually, the thin slice CT-scan demonstrated the presence of two small osteolytic lesions in these areas. In conclusion, the simultaneous acquisition of images both from I-131 and a bone-seeking agent may be useful to locate functioning bone metastases from DTC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15648552     DOI: 10.1007/BF03346282

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  11 in total

1.  Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.

Authors:  C Pérault; C Schvartz; H Wampach; J C Liehn; M J Delisle
Journal:  J Nucl Med       Date:  1997-08       Impact factor: 10.057

2.  Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age.

Authors:  T Petrich; A Widjaja; T J Musholt; M Hofmann; T Brunkhorst; C Ehrenheim; G Oetting; W H Knapp
Journal:  Eur J Nucl Med       Date:  2001-02

3.  US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer.

Authors:  R T Sutton; C C Reading; J W Charboneau; E M James; C S Grant; I D Hay
Journal:  Radiology       Date:  1988-09       Impact factor: 11.105

4.  Undetectable serum thyroglobulin in a patient with metastatic follicular thyroid cancer.

Authors:  I J Mertens; J M De Klerk; P M Zelissen; J H Thijssen; D M Sie-Go; S H Han; P P Van Rijk
Journal:  Clin Nucl Med       Date:  1999-05       Impact factor: 7.794

5.  Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma.

Authors:  C Marcocci; F Pacini; R Elisei; E Schipani; C Ceccarelli; P Miccoli; M Arganini; A Pinchera
Journal:  Surgery       Date:  1989-12       Impact factor: 3.982

6.  Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma.

Authors:  F Pacini; E Molinaro; M G Castagna; L Agate; R Elisei; C Ceccarelli; F Lippi; D Taddei; L Grasso; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

7.  Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine.

Authors:  F Pacini; F Cetani; P Miccoli; F Mancusi; C Ceccarelli; F Lippi; E Martino; A Pinchera
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

8.  Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case report.

Authors:  L S Freudenberg; G Antoch; R Görges; J Knust; R Pink; W Jentzen; J F Debatin; W Brandau; A Bockisch; J Stattaus
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

9.  [Chest X ray: routine indication in the follow-up of differentiated thyroid cancer?].

Authors:  J Lorenzen; M Beese; J Mester; K Brumma; W Beyer; M Clausen
Journal:  Nuklearmedizin       Date:  1998       Impact factor: 1.379

10.  Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal.

Authors:  Furio Pacini; Eleonora Molinaro; Maria Grazia Castagna; Francesco Lippi; Claudia Ceccarelli; Laura Agate; Rossella Elisei; Aldo Pinchera
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

View more
  2 in total

1.  Detection of metastases from differentiated thyroid cancer by different imaging techniques (neck ultrasound, computed tomography and [18F]-FDG positron emission tomography) in patients with negative post-therapeutic ¹³¹I whole-body scan and detectable serum thyroglobulin levels.

Authors:  Laura Agate; Francesca Bianchi; A Giorgetti; P Sbragia; V Bottici; F Brozzi; P Santini; E Molinaro; P Vitti; R Elisei; C Ceccarelli
Journal:  J Endocrinol Invest       Date:  2014-07-29       Impact factor: 4.256

2.  Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours.

Authors:  James C Knight; Michael J Mosley; Veerle Kersemans; Gemma M Dias; P Danny Allen; Sean Smart; Bart Cornelissen
Journal:  Nucl Med Biol       Date:  2019-02-05       Impact factor: 2.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.